insights - IMS Health

NEWS | IMS ONCOLOGY EXPERTISE
The IMS HEOR Bibliography captures more than 2200 research publications with a history
of 25 years across all key therapy areas. Oncology is one of our leading fields of research.
Oncology is a key research area for IMS HEOR
The oncology market is experiencing spectacular
growth and unprecedented innovation.
It is predicted to become the largest single therapy
sector in value terms by 2015 – worth US$75 billion.
New molecular targeted therapies, diagnostics,
genomics and proteomics are changing the face of
cancer treatment, spurring exciting opportunities
- and also new challenges - for this healthcare
sector worldwide.
The IMS HEOR global team has completed projects
on 20 different tumor types, spanning all aspects
of health economics and outcomes research, with
particular emphasis on health economic modeling
and retrospective outcomes research.
The top ten cancers we have covered are:
1. Breast
2. Lung [NSCLC/SCLC]
3. Colorectal
4. Lymphoma
5. Melanoma/BCC
6. Prostate
7. Multiple myeloma
8. Leukemias [CLL/CML]
9. Mesothelioma
10. Cervical
IMS HEOR ONCOLOGY PROJECTS SPAN ALL ASPECTS OF HEOR
43%
ONCOLOGY IS A LEADING AREA OF IMS HEOR EXPERTISE
116 107
PAGE 4 IMS HEALTH ECONOMICS & OUTCOMES RESEARCH
150
233
259
330
Diabetes Oncology Cardiovascular
Mental health
HE modeling
Prospective
outcomes research
Neurological
disorders
14%
30%
13%
Retrospective
outcomes research
Value
communications
Respiratory
diseases